Dupilumab
Products Dupilumab was approved as a solution for injection in the United States and EU in 2017 and in many countries in 2019 (Dupixent). Structure and properties Dupilumab is a human recombinant IgG4 monoclonal antibody with a molecular mass of 147 kDa. It is produced by biotechnological methods. Effects Dupilumab (ATC D11AH05) has anti-inflammatory and … Dupilumab